Nicanord Ernst J, Lee Wei-Chen Miso, Konopnicki Sarah A, Campbell Kendall
Family Medicine, University of Texas Medical Branch at Galveston, Galveston, USA.
Cureus. 2025 Feb 17;17(2):e79175. doi: 10.7759/cureus.79175. eCollection 2025 Feb.
The opioid epidemic remains a significant public health challenge, with a substantial number of overdose deaths occurring annually. Synthetic opioids, particularly illicitly manufactured fentanyl, account for a significant portion of these fatalities, with a notable increase in adolescent deaths. In Texas, despite a decrease in opioid prescriptions, overdose deaths from both legal and illegal opioids have increased. The state's current overdose tracking program lacks comprehensive reporting, suggesting the crisis may be worse than reported due to incomplete data from rural counties affected by border crossings. This paper examines the pattern of opioid overdose deaths in Texas over the last seven years and postulates that the extent of the opioid crisis in Texas may be worse than what is officially reported due to incomplete data from rural counties.
This study presents a trend analysis based on the Texas Department of State Health Services' surveillance data from 2016 to 2022. The analysis highlights trends in total polysubstance and drug-related deaths, the number of affected counties, and the average number of deaths per county. Additionally, the study identifies counties with increasing death rates over the seven-year period.
The analysis revealed a consistent increase in drug-related and polysubstance-related deaths from 2016 to 2022, along with a rise in the number of counties reporting these deaths. Additionally, a statistically significant association was found between the year and the number of deaths. The data indicates the significant impact of the COVID-19 pandemic, as evidenced by a dramatic surge in polysubstance-related deaths from 2019 to 2020.
The opioid crisis in Texas calls for a comprehensive strategy that includes improved data collection, equitable resource distribution, and evidence-based legislative reforms. This approach, which should be guided by empirical data, would not only address the immediate crisis but would also contribute to the broader discourse on public health policy and practice.
阿片类药物泛滥仍然是一项重大的公共卫生挑战，每年有大量过量用药死亡事件发生。合成阿片类药物，尤其是非法制造的芬太尼，在这些死亡事件中占很大比例，青少年死亡人数显著增加。在得克萨斯州，尽管阿片类药物处方量有所下降，但合法和非法阿片类药物导致的过量用药死亡人数却有所增加。该州目前的过量用药追踪计划缺乏全面报告，这表明由于受边境过境影响的农村县数据不完整，危机可能比报告的更严重。本文研究了得克萨斯州过去七年阿片类药物过量用药死亡的模式，并推测由于农村县数据不完整，得克萨斯州阿片类药物危机的程度可能比官方报告的更严重。
本研究基于得克萨斯州州立卫生服务部2016年至2022年的监测数据进行趋势分析。该分析突出了多物质和与药物相关的死亡总数、受影响县的数量以及每个县的平均死亡人数的趋势。此外，该研究还确定了在这七年期间死亡率上升的县。
分析显示，2016年至2022年期间，与药物相关和与多物质相关的死亡人数持续增加，报告这些死亡事件的县的数量也有所增加。此外，还发现年份与死亡人数之间存在统计学上的显著关联。数据表明了新冠疫情的重大影响，2019年至2020年多物质相关死亡人数急剧增加就证明了这一点。
得克萨斯州的阿片类药物危机需要一项全面战略，包括改进数据收集、公平资源分配和基于证据的立法改革。这种以实证数据为指导的方法不仅能应对当前的危机，还将有助于更广泛地讨论公共卫生政策和实践。
